Serum NT-proBNP Concentrations in the Early Phase Do Not Predict the Severity of Systolic or Diastolic Left Ventricular Dysfunction Among Patients With ST-Elevation Acute Myocardial Infarction
@article{bendor2006SerumNC,
title={Serum NT-proBNP Concentrations in the Early Phase Do Not Predict the Severity of Systolic or Diastolic Left Ventricular Dysfunction Among Patients With ST-Elevation Acute Myocardial Infarction},
author={itsik ben-dor and Moti Haim and Eldad Rechavia and Daniel Murninkas and Daniella Harell and Avital Porter and Zaza Iakobishvili and Alexander Battler and David Hasdai},
journal={Angiology},
year={2006},
volume={57},
pages={686 - 693}
}The cohort included 55 consecutive patients with first ST elevation acute myocardial infarction (STEAMI) who underwent reperfusion. Blood samples were drawn for N-terminal pro B-type natriuretic peptide (NT-proBNP), highly-sensitive C-reactive protein (hs-CRP), creatinine kinase (CK), cardiac troponin l (cTnl), and white blood cell (WBC) count within 24 hours of admission. Transthoracic echocardiography, performed within the same time frame, assessed left ventricular (LV) systolic function, as…
5 Citations
A Clinical Study of N-Terminal Pro- Brain Natriuretic Peptide as A Predictor of Prognosis in Acute St Segment Elevation Myocardial Infarction in Comparison with Left Ventricular Ejection Fraction
- Medicine
- 2018
NT-proBNP is a strong predictor of short term outcome in STEMI and better short term prognostic indicator than LVEF, and can be utilized as a good tool for risk stratification of acute MI patients so that appropriate treatment strategies could be planned.
Oxidative stress markers predict early left ventricular systolic dysfunction after acute myocardial infarction treated with primary percutaneous coronary intervention.
- Medicine, BiologyAdvances in clinical and experimental medicine : official organ Wroclaw Medical University
- 2018
It is shown for the first time that thiol groups and catalase are independent predictors of STEMI complication - LVSD and acute HF, respectively.
B-type natriuretic peptide is a prognostic marker after myocardial infarction: Two-years survival study of 86 patients
- Medicine, Biology
- 2010
C Valvular heart disease Percutaneous valve aortic valve replacement : time to expand ?
- Medicine
- 2008
This bibliography contains every paper annotated by reviewers; these references were obtained from a variety of bibliographic databases and published between the beginning of the review period and the time of going to press.
Pozaszpitalne zapalenia płuc u osób w wieku podeszłym Community-acquired pneumonia in elderly
- Medicine, Biology
- 2011
Recent epidemiological data, diagnostic criteria and therapeutic recommendations for community-acquired pneumonia in the elderly are presented.
References
SHOWING 1-10 OF 39 REFERENCES
Usefulness of B-type natriuretic peptide in hypertensive patients with exertional dyspnea and normal left ventricular ejection fraction and correlation with new echocardiographic indexes of systolic and diastolic function.
- MedicineThe American journal of cardiology
- 2003
Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction.
- Medicine, BiologyEuropean heart journal
- 2000
Plasma N-terminal pro-brain natriuretic peptide measured later in hospitalization better predicts poor outcome following myocardial infarction than when it is measured in the immediate post infarctions period.
Rapid Determination of Brain Natriuretic Peptide in Patients with Acute Myocardial Infarction
- Medicine, BiologyClinical chemistry and laboratory medicine
- 2003
The sensitivity and specificity of BNP for predicting survival of patients over 1 year of follow-up was 100% and 43%, respectively, with a negative predictive value of 100%.
Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care
- MedicineBMJ
- 1998
Blood natriuretic peptide concentrations are not useful in identifying important left ventricular systolic dysfunction in stable survivors of myocardial infarction.
N‐Terminal Pro‐Brain Natriuretic Peptide and Other Risk Markers for the Separate Prediction of Mortality and Subsequent Myocardial Infarction in Patients With Unstable Coronary Artery Disease: A Global Utilization of Strategies To Open occluded arteries (GUSTO)‐IV Substudy
- Medicine, BiologyCirculation
- 2003
The use of N‐terminal pro‐brain natriuretic peptide appears to add critical prognostic insight to the assessment of patients with ACS, and the combination of NT‐proBNP and creatinine clearance provided the best prediction.
Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction.
- Medicine, BiologyAmerican heart journal
- 1998
Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods.
- MedicineBritish heart journal
- 1994
Left ventricular dysfunction is easily and reliably detected by echocardiographic measurement of LVEF and also by a quick qualitative echOCardiographic assessment but is likely to be missed by clinical assessment alone.
The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.
- MedicineThe New England journal of medicine
- 2001
A single measurement of B-type natriuretic peptide, obtained in the first few days after the onset of ischemic symptoms, provides powerful information for use in risk stratification across the spectrum of acute coronary syndromes, and suggests that cardiac neurohormonal activation may be a unifying feature among patients at high risk for death after acute coronary syndrome.
Natriuretic peptides for risk stratification of patients with acute coronary syndromes
- Medicine, BiologyEuropean journal of heart failure
- 2004
Utility of B-Natriuretic Peptide in Detecting Diastolic Dysfunction
- Medicine
- 2002
It is hypothesized that B-natriuretic peptide levels could predict diastolic abnormalities in patients with normal systolic function, and 294 patients referred for echocardiography were studied to evaluate ventricular function.



